Home > > > > > Report Detail

Global Hypertension Drug Market Growth 2023-2029

Publisher Name :
Date: 02-Feb-2023
No. of pages: 102

Hypertension or high blood pressure is the condition when blood pressure increases to the unhealthy level. Hypertension is very harmful and it can lead to stroke, heart failure, heart attack and kidney diseases. The main purpose of anti-hypertension drug is to lower and control high blood pressure to protect organs like brain, heart, kidneys.

LPI (LP Information)' newest research report, the "Hypertension Drug Industry Forecast" looks at past sales and reviews total world Hypertension Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Hypertension Drug sales for 2023 through 2029. With Hypertension Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hypertension Drug industry.

This Insight Report provides a comprehensive analysis of the global Hypertension Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hypertension Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hypertension Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hypertension Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hypertension Drug.

The global Hypertension Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Change in lifestyle and elevated stress levels have increased the prevalence of hypertension globally, thereby increasing the demand for hypertension drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Hypertension Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Calcium Channel Blockers

- Diuretics

- Beta Blockers Vasodilators

- Angiotensin Converting Enzyme Inhibitors

- Alpha Blockers

- Angiotensin Receptor Blockers

- Renin Inhibitors

Segmentation by application

- Hospital

- Private Clinic

- Others

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Lupin Limited

- Novartis AG

- Daiichi - Sankyo

- Pfizer Inc

- Ranbaxy Laboratories Limited

- Sanofi S.A

- AstraZeneca Plc

- Johnson & Johnson Ltd

- Boehringer Ingelheim

- Merck & Co.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hypertension Drug market?

What factors are driving Hypertension Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hypertension Drug market opportunities vary by end market size?

How does Hypertension Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Hypertension Drug Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hypertension Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Hypertension Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Hypertension Drug by Country/Region, 2018, 2022 & 2029
2.2 Hypertension Drug Segment by Type
2.2.1 Calcium Channel Blockers
2.2.2 Diuretics
2.2.3 Beta Blockers Vasodilators
2.2.4 Angiotensin Converting Enzyme Inhibitors
2.2.5 Alpha Blockers
2.2.6 Angiotensin Receptor Blockers
2.2.7 Renin Inhibitors
2.3 Hypertension Drug Sales by Type
2.3.1 Global Hypertension Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Hypertension Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Hypertension Drug Sale Price by Type (2018-2023)
2.4 Hypertension Drug Segment by Application
2.4.1 Hospital
2.4.2 Private Clinic
2.4.3 Others
2.5 Hypertension Drug Sales by Application
2.5.1 Global Hypertension Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Hypertension Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Hypertension Drug Sale Price by Application (2018-2023)
3 Global Hypertension Drug by Company
3.1 Global Hypertension Drug Breakdown Data by Company
3.1.1 Global Hypertension Drug Annual Sales by Company (2018-2023)
3.1.2 Global Hypertension Drug Sales Market Share by Company (2018-2023)
3.2 Global Hypertension Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Hypertension Drug Revenue by Company (2018-2023)
3.2.2 Global Hypertension Drug Revenue Market Share by Company (2018-2023)
3.3 Global Hypertension Drug Sale Price by Company
3.4 Key Manufacturers Hypertension Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hypertension Drug Product Location Distribution
3.4.2 Players Hypertension Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hypertension Drug by Geographic Region
4.1 World Historic Hypertension Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Hypertension Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Hypertension Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Hypertension Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Hypertension Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Hypertension Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Hypertension Drug Sales Growth
4.4 APAC Hypertension Drug Sales Growth
4.5 Europe Hypertension Drug Sales Growth
4.6 Middle East & Africa Hypertension Drug Sales Growth
5 Americas
5.1 Americas Hypertension Drug Sales by Country
5.1.1 Americas Hypertension Drug Sales by Country (2018-2023)
5.1.2 Americas Hypertension Drug Revenue by Country (2018-2023)
5.2 Americas Hypertension Drug Sales by Type
5.3 Americas Hypertension Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hypertension Drug Sales by Region
6.1.1 APAC Hypertension Drug Sales by Region (2018-2023)
6.1.2 APAC Hypertension Drug Revenue by Region (2018-2023)
6.2 APAC Hypertension Drug Sales by Type
6.3 APAC Hypertension Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hypertension Drug by Country
7.1.1 Europe Hypertension Drug Sales by Country (2018-2023)
7.1.2 Europe Hypertension Drug Revenue by Country (2018-2023)
7.2 Europe Hypertension Drug Sales by Type
7.3 Europe Hypertension Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hypertension Drug by Country
8.1.1 Middle East & Africa Hypertension Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Hypertension Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Hypertension Drug Sales by Type
8.3 Middle East & Africa Hypertension Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hypertension Drug
10.3 Manufacturing Process Analysis of Hypertension Drug
10.4 Industry Chain Structure of Hypertension Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hypertension Drug Distributors
11.3 Hypertension Drug Customer
12 World Forecast Review for Hypertension Drug by Geographic Region
12.1 Global Hypertension Drug Market Size Forecast by Region
12.1.1 Global Hypertension Drug Forecast by Region (2024-2029)
12.1.2 Global Hypertension Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hypertension Drug Forecast by Type
12.7 Global Hypertension Drug Forecast by Application
13 Key Players Analysis
13.1 Lupin Limited
13.1.1 Lupin Limited Company Information
13.1.2 Lupin Limited Hypertension Drug Product Portfolios and Specifications
13.1.3 Lupin Limited Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Lupin Limited Main Business Overview
13.1.5 Lupin Limited Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Hypertension Drug Product Portfolios and Specifications
13.2.3 Novartis AG Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 Daiichi - Sankyo
13.3.1 Daiichi - Sankyo Company Information
13.3.2 Daiichi - Sankyo Hypertension Drug Product Portfolios and Specifications
13.3.3 Daiichi - Sankyo Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Daiichi - Sankyo Main Business Overview
13.3.5 Daiichi - Sankyo Latest Developments
13.4 Pfizer Inc
13.4.1 Pfizer Inc Company Information
13.4.2 Pfizer Inc Hypertension Drug Product Portfolios and Specifications
13.4.3 Pfizer Inc Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Inc Main Business Overview
13.4.5 Pfizer Inc Latest Developments
13.5 Ranbaxy Laboratories Limited
13.5.1 Ranbaxy Laboratories Limited Company Information
13.5.2 Ranbaxy Laboratories Limited Hypertension Drug Product Portfolios and Specifications
13.5.3 Ranbaxy Laboratories Limited Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Ranbaxy Laboratories Limited Main Business Overview
13.5.5 Ranbaxy Laboratories Limited Latest Developments
13.6 Sanofi S.A
13.6.1 Sanofi S.A Company Information
13.6.2 Sanofi S.A Hypertension Drug Product Portfolios and Specifications
13.6.3 Sanofi S.A Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanofi S.A Main Business Overview
13.6.5 Sanofi S.A Latest Developments
13.7 AstraZeneca Plc
13.7.1 AstraZeneca Plc Company Information
13.7.2 AstraZeneca Plc Hypertension Drug Product Portfolios and Specifications
13.7.3 AstraZeneca Plc Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AstraZeneca Plc Main Business Overview
13.7.5 AstraZeneca Plc Latest Developments
13.8 Johnson & Johnson Ltd
13.8.1 Johnson & Johnson Ltd Company Information
13.8.2 Johnson & Johnson Ltd Hypertension Drug Product Portfolios and Specifications
13.8.3 Johnson & Johnson Ltd Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Johnson & Johnson Ltd Main Business Overview
13.8.5 Johnson & Johnson Ltd Latest Developments
13.9 Boehringer Ingelheim
13.9.1 Boehringer Ingelheim Company Information
13.9.2 Boehringer Ingelheim Hypertension Drug Product Portfolios and Specifications
13.9.3 Boehringer Ingelheim Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Boehringer Ingelheim Main Business Overview
13.9.5 Boehringer Ingelheim Latest Developments
13.10 Merck & Co.
13.10.1 Merck & Co. Company Information
13.10.2 Merck & Co. Hypertension Drug Product Portfolios and Specifications
13.10.3 Merck & Co. Hypertension Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merck & Co. Main Business Overview
13.10.5 Merck & Co. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Hypertension Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Hypertension Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Calcium Channel Blockers
Table 4. Major Players of Diuretics
Table 5. Major Players of Beta Blockers Vasodilators
Table 6. Major Players of Angiotensin Converting Enzyme Inhibitors
Table 7. Major Players of Alpha Blockers
Table 8. Major Players of Angiotensin Receptor Blockers
Table 9. Major Players of Renin Inhibitors
Table 10. Global Hypertension Drug Sales by Type (2018-2023) & (K Units)
Table 11. Global Hypertension Drug Sales Market Share by Type (2018-2023)
Table 12. Global Hypertension Drug Revenue by Type (2018-2023) & ($ million)
Table 13. Global Hypertension Drug Revenue Market Share by Type (2018-2023)
Table 14. Global Hypertension Drug Sale Price by Type (2018-2023) & (USD/Unit)
Table 15. Global Hypertension Drug Sales by Application (2018-2023) & (K Units)
Table 16. Global Hypertension Drug Sales Market Share by Application (2018-2023)
Table 17. Global Hypertension Drug Revenue by Application (2018-2023)
Table 18. Global Hypertension Drug Revenue Market Share by Application (2018-2023)
Table 19. Global Hypertension Drug Sale Price by Application (2018-2023) & (USD/Unit)
Table 20. Global Hypertension Drug Sales by Company (2018-2023) & (K Units)
Table 21. Global Hypertension Drug Sales Market Share by Company (2018-2023)
Table 22. Global Hypertension Drug Revenue by Company (2018-2023) ($ Millions)
Table 23. Global Hypertension Drug Revenue Market Share by Company (2018-2023)
Table 24. Global Hypertension Drug Sale Price by Company (2018-2023) & (USD/Unit)
Table 25. Key Manufacturers Hypertension Drug Producing Area Distribution and Sales Area
Table 26. Players Hypertension Drug Products Offered
Table 27. Hypertension Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Hypertension Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 31. Global Hypertension Drug Sales Market Share Geographic Region (2018-2023)
Table 32. Global Hypertension Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 33. Global Hypertension Drug Revenue Market Share by Geographic Region (2018-2023)
Table 34. Global Hypertension Drug Sales by Country/Region (2018-2023) & (K Units)
Table 35. Global Hypertension Drug Sales Market Share by Country/Region (2018-2023)
Table 36. Global Hypertension Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 37. Global Hypertension Drug Revenue Market Share by Country/Region (2018-2023)
Table 38. Americas Hypertension Drug Sales by Country (2018-2023) & (K Units)
Table 39. Americas Hypertension Drug Sales Market Share by Country (2018-2023)
Table 40. Americas Hypertension Drug Revenue by Country (2018-2023) & ($ Millions)
Table 41. Americas Hypertension Drug Revenue Market Share by Country (2018-2023)
Table 42. Americas Hypertension Drug Sales by Type (2018-2023) & (K Units)
Table 43. Americas Hypertension Drug Sales by Application (2018-2023) & (K Units)
Table 44. APAC Hypertension Drug Sales by Region (2018-2023) & (K Units)
Table 45. APAC Hypertension Drug Sales Market Share by Region (2018-2023)
Table 46. APAC Hypertension Drug Revenue by Region (2018-2023) & ($ Millions)
Table 47. APAC Hypertension Drug Revenue Market Share by Region (2018-2023)
Table 48. APAC Hypertension Drug Sales by Type (2018-2023) & (K Units)
Table 49. APAC Hypertension Drug Sales by Application (2018-2023) & (K Units)
Table 50. Europe Hypertension Drug Sales by Country (2018-2023) & (K Units)
Table 51. Europe Hypertension Drug Sales Market Share by Country (2018-2023)
Table 52. Europe Hypertension Drug Revenue by Country (2018-2023) & ($ Millions)
Table 53. Europe Hypertension Drug Revenue Market Share by Country (2018-2023)
Table 54. Europe Hypertension Drug Sales by Type (2018-2023) & (K Units)
Table 55. Europe Hypertension Drug Sales by Application (2018-2023) & (K Units)
Table 56. Middle East & Africa Hypertension Drug Sales by Country (2018-2023) & (K Units)
Table 57. Middle East & Africa Hypertension Drug Sales Market Share by Country (2018-2023)
Table 58. Middle East & Africa Hypertension Drug Revenue by Country (2018-2023) & ($ Millions)
Table 59. Middle East & Africa Hypertension Drug Revenue Market Share by Country (2018-2023)
Table 60. Middle East & Africa Hypertension Drug Sales by Type (2018-2023) & (K Units)
Table 61. Middle East & Africa Hypertension Drug Sales by Application (2018-2023) & (K Units)
Table 62. Key Market Drivers & Growth Opportunities of Hypertension Drug
Table 63. Key Market Challenges & Risks of Hypertension Drug
Table 64. Key Industry Trends of Hypertension Drug
Table 65. Hypertension Drug Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Hypertension Drug Distributors List
Table 68. Hypertension Drug Customer List
Table 69. Global Hypertension Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 70. Global Hypertension Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Americas Hypertension Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Americas Hypertension Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. APAC Hypertension Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 74. APAC Hypertension Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 75. Europe Hypertension Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Europe Hypertension Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Middle East & Africa Hypertension Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 78. Middle East & Africa Hypertension Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 79. Global Hypertension Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 80. Global Hypertension Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 81. Global Hypertension Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 82. Global Hypertension Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 83. Lupin Limited Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Lupin Limited Hypertension Drug Product Portfolios and Specifications
Table 85. Lupin Limited Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Lupin Limited Main Business
Table 87. Lupin Limited Latest Developments
Table 88. Novartis AG Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis AG Hypertension Drug Product Portfolios and Specifications
Table 90. Novartis AG Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Novartis AG Main Business
Table 92. Novartis AG Latest Developments
Table 93. Daiichi - Sankyo Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Daiichi - Sankyo Hypertension Drug Product Portfolios and Specifications
Table 95. Daiichi - Sankyo Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Daiichi - Sankyo Main Business
Table 97. Daiichi - Sankyo Latest Developments
Table 98. Pfizer Inc Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Inc Hypertension Drug Product Portfolios and Specifications
Table 100. Pfizer Inc Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Pfizer Inc Main Business
Table 102. Pfizer Inc Latest Developments
Table 103. Ranbaxy Laboratories Limited Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Ranbaxy Laboratories Limited Hypertension Drug Product Portfolios and Specifications
Table 105. Ranbaxy Laboratories Limited Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Ranbaxy Laboratories Limited Main Business
Table 107. Ranbaxy Laboratories Limited Latest Developments
Table 108. Sanofi S.A Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Sanofi S.A Hypertension Drug Product Portfolios and Specifications
Table 110. Sanofi S.A Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Sanofi S.A Main Business
Table 112. Sanofi S.A Latest Developments
Table 113. AstraZeneca Plc Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Plc Hypertension Drug Product Portfolios and Specifications
Table 115. AstraZeneca Plc Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. AstraZeneca Plc Main Business
Table 117. AstraZeneca Plc Latest Developments
Table 118. Johnson & Johnson Ltd Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Johnson & Johnson Ltd Hypertension Drug Product Portfolios and Specifications
Table 120. Johnson & Johnson Ltd Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Johnson & Johnson Ltd Main Business
Table 122. Johnson & Johnson Ltd Latest Developments
Table 123. Boehringer Ingelheim Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Boehringer Ingelheim Hypertension Drug Product Portfolios and Specifications
Table 125. Boehringer Ingelheim Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Boehringer Ingelheim Main Business
Table 127. Boehringer Ingelheim Latest Developments
Table 128. Merck & Co. Basic Information, Hypertension Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Merck & Co. Hypertension Drug Product Portfolios and Specifications
Table 130. Merck & Co. Hypertension Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Merck & Co. Main Business
Table 132. Merck & Co. Latest Developments
List of Figures
Figure 1. Picture of Hypertension Drug
Figure 2. Hypertension Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hypertension Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Hypertension Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Hypertension Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Calcium Channel Blockers
Figure 10. Product Picture of Diuretics
Figure 11. Product Picture of Beta Blockers Vasodilators
Figure 12. Product Picture of Angiotensin Converting Enzyme Inhibitors
Figure 13. Product Picture of Alpha Blockers
Figure 14. Product Picture of Angiotensin Receptor Blockers
Figure 15. Product Picture of Renin Inhibitors
Figure 16. Global Hypertension Drug Sales Market Share by Type in 2022
Figure 17. Global Hypertension Drug Revenue Market Share by Type (2018-2023)
Figure 18. Hypertension Drug Consumed in Hospital
Figure 19. Global Hypertension Drug Market: Hospital (2018-2023) & (K Units)
Figure 20. Hypertension Drug Consumed in Private Clinic
Figure 21. Global Hypertension Drug Market: Private Clinic (2018-2023) & (K Units)
Figure 22. Hypertension Drug Consumed in Others
Figure 23. Global Hypertension Drug Market: Others (2018-2023) & (K Units)
Figure 24. Global Hypertension Drug Sales Market Share by Application (2022)
Figure 25. Global Hypertension Drug Revenue Market Share by Application in 2022
Figure 26. Hypertension Drug Sales Market by Company in 2022 (K Units)
Figure 27. Global Hypertension Drug Sales Market Share by Company in 2022
Figure 28. Hypertension Drug Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Hypertension Drug Revenue Market Share by Company in 2022
Figure 30. Global Hypertension Drug Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Hypertension Drug Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Hypertension Drug Sales 2018-2023 (K Units)
Figure 33. Americas Hypertension Drug Revenue 2018-2023 ($ Millions)
Figure 34. APAC Hypertension Drug Sales 2018-2023 (K Units)
Figure 35. APAC Hypertension Drug Revenue 2018-2023 ($ Millions)
Figure 36. Europe Hypertension Drug Sales 2018-2023 (K Units)
Figure 37. Europe Hypertension Drug Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Hypertension Drug Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Hypertension Drug Revenue 2018-2023 ($ Millions)
Figure 40. Americas Hypertension Drug Sales Market Share by Country in 2022
Figure 41. Americas Hypertension Drug Revenue Market Share by Country in 2022
Figure 42. Americas Hypertension Drug Sales Market Share by Type (2018-2023)
Figure 43. Americas Hypertension Drug Sales Market Share by Application (2018-2023)
Figure 44. United States Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Hypertension Drug Sales Market Share by Region in 2022
Figure 49. APAC Hypertension Drug Revenue Market Share by Regions in 2022
Figure 50. APAC Hypertension Drug Sales Market Share by Type (2018-2023)
Figure 51. APAC Hypertension Drug Sales Market Share by Application (2018-2023)
Figure 52. China Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Hypertension Drug Sales Market Share by Country in 2022
Figure 60. Europe Hypertension Drug Revenue Market Share by Country in 2022
Figure 61. Europe Hypertension Drug Sales Market Share by Type (2018-2023)
Figure 62. Europe Hypertension Drug Sales Market Share by Application (2018-2023)
Figure 63. Germany Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Hypertension Drug Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Hypertension Drug Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Hypertension Drug Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Hypertension Drug Sales Market Share by Application (2018-2023)
Figure 72. Egypt Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Hypertension Drug Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Hypertension Drug in 2022
Figure 78. Manufacturing Process Analysis of Hypertension Drug
Figure 79. Industry Chain Structure of Hypertension Drug
Figure 80. Channels of Distribution
Figure 81. Global Hypertension Drug Sales Market Forecast by Region (2024-2029)
Figure 82. Global Hypertension Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Hypertension Drug Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Hypertension Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Hypertension Drug Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Hypertension Drug Revenue Market Share Forecast by Application (2024-2029)
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs